As shown in Figure S3, YTHDC2 expression was significantly correlated with molecular subtypes in ACC, BRCA, COAD, HNSC, LGG, pheochromocytoma and paraganglioma (PCPG), PRAD, stomach adenocarcinoma (STAD) and UCEC. This evidence concerns the gene YTHDC2 and prostate adenocarcinoma.